glp-1 and liver cirrhosis Therapies Reduce Risk of Cirrhosis, Complications of MASLD The Emerging Role of Glucagon-Like

Its a combination of all three of these factors. Since the study was retrospective, it is not enough to change practice, so large randomized clinical trials addressing this question are needed, Sheth said

P., & Eid, T

S.QuinnJ.ReddyP

Fr ytterligare kommentarer vnligen kontakta: Hans Flink , Affrsutvecklingschef Svensk Mklarstatistik 070-6351650 Per-Arne Sandegren , Analyschef Svensk Mklarstatistik 08-588 00 452 Oskar holm , vd Mklarsamfundet, 070-350 96 61

Discussion In this systematic review and meta-analysis we summarised and synthesised the most up-to-date data from RCTs of once-weekly tirzepatide in individuals with type 2 diabetes